F-1/A: Epsium Enterprise Limited Files Amendment No. 10 to Form F-1 for IPO
Amendment to Registration Statement
Epsium Enterprise Limited files an amendment to its Form F-1 registration statement, updating the underwriter information and detailing the offering structure.
Summary
- Epsium Enterprise Limited has filed Amendment No. 10 to its Form F-1 registration statement.
- D. Boral Capital LLC will act as the representative of the underwriters, replacing Benjamin Securities, Inc.
- The offering includes a public offering of 1,250,000 Ordinary Shares and a potential resale of 1,159,534 Ordinary Shares by selling shareholders.
- The resale offering is contingent on the listing of Ordinary Shares on the Nasdaq and the consummation of the initial public offering.
- The expected initial public offering price is between $4.00 and $5.00 per Ordinary Share.
- The company will reserve the symbol EPSM for listing on the Nasdaq.
- The company's operations are conducted through Companhia de Comercio Luz Limitada in Macau.
- The company's structure involves entities in the British Virgin Islands, Hong Kong, and Macau, which presents unique risks to investors.
- The company is subject to laws and regulations in Macau and may be indirectly affected by PRC laws.
- The company's Macau counsel has advised that the company is not required to obtain permissions or approvals from any PRC national authorities to operate their businesses or to issue the Ordinary Shares to foreign investors.
Sentiment
Score: 6
Explanation: The document is primarily factual, outlining the terms of the IPO and related agreements. While there are risks mentioned, the overall tone is neutral, aiming to inform potential investors.
Positives
- The company has secured D. Boral Capital LLC as the lead underwriter for its IPO.
- The company is proceeding with its plans to list on the Nasdaq Capital Market.
- The company's Macau counsel has advised that the company is not required to obtain permissions or approvals from any PRC national authorities to operate their businesses or to issue the Ordinary Shares to foreign investors.
Negatives
- The resale offering is contingent on the Nasdaq listing and IPO completion, creating uncertainty for selling shareholders.
- The company's structure involves entities in the British Virgin Islands, Hong Kong, and Macau, which presents unique risks to investors.
- The company is subject to laws and regulations in Macau and may be indirectly affected by PRC laws.
Risks
- The resale offering is contingent on the Nasdaq listing and IPO completion.
- The company's structure involves entities in the British Virgin Islands, Hong Kong, and Macau, which presents unique risks to investors.
- The company is subject to laws and regulations in Macau and may be indirectly affected by PRC laws.
- Changes in political and legal arrangements in Macau or Hong Kong could impact the company.
- PRC regulatory authorities could disallow the company structure.
- The company's business operations rely on the economic growth of the PRC.
Future Outlook
The company intends to use the proceeds from the offering for sales and product innovation, acquisitions or investments, general corporate purposes, and as a reserve.
Industry Context
The announcement reflects a company navigating the complexities of operating in Macau, a special administrative region of China, while seeking to access international capital markets. It highlights the importance of regulatory compliance and the potential impact of geopolitical factors on business operations.
Comparison to Industry Standards
- The document does not provide enough information to make a detailed comparison to industry standards.
- However, the company's reliance on a single underwriter is common for smaller IPOs.
- The 8% underwriting discount is within the typical range for similar offerings.
- The company's focus on the Macau market is unique, as most comparable companies operate in larger, more diversified markets.
Stakeholder Impact
- Shareholders will be affected by the potential dilution from the offering and the risks associated with the company's structure and operations.
- Employees may be affected by the company's ability to execute its growth strategies and maintain financial stability.
- Customers may be affected by the company's ability to maintain its supply chain and offer competitive products.
Next Steps
- The company will proceed with the initial public offering and listing on the Nasdaq Capital Market.
- The company will work to maintain compliance with all applicable regulations.
- The company will implement its plans for using the proceeds from the offering.
Key Dates
| Date | Description |
|---|---|
| March 12, 2020 | Epsium HK was set up in Hong Kong, SAR China. |
| March 24, 2020 | Epsium BVI was established in British Virgin Islands. |
| May 17, 2021 | Epsium BVI purchased 8,000 shares of Epsium HK from Mr. Chi Long Lou. |
| May 17, 2021 | Mr. Son I Tam purchased 1,900 shares of Epsium HK from Mr. Chi Long Lou. |
| February 17, 2023 | China Securities Regulatory Commission (the CSRC) promulgated the Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies (the Trial Measures). |
| March 31, 2023 | The Trial Measures became effective. |
| February 8, 2024 | The Company accepted the surrender of shares by each shareholder of the Company (the Share Surrender) and approved the cancellation of the surrendered shares (the Share Cancellation). |
| March 10, 2025 | Date of Preliminary Prospectus. |
| [], 2025 | Expected date of Prospectus. |
| [], 2025 | Expected date of closing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.